|
|
This unique CD-ROM database product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. The database contains extensive corporate, R&D, and business collaboration information. The company profile database covers over 150 companies from 18 different countries. The R&D database covers over 160 pipeline drugs from early stage as target validation to late stage as phase III. All projects have as far as possible been assigned with specified targets, such as IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune modulator etc. In the collaboration database more than 80 unique business collaborations have been described. "HCV R&D and Business Development Database" is also the basis for the analytical report Competitive Outlook on HCV: What to Know & Expect in R&D and Business Development. Both these products are included in the Analytical Tool: Competitive Outlook in HCV The "HCV R&D and Business Development Database " is a collection of three databases: Company Profiles, R&D Projects and Business Collaborations Databases Company Profiles R&D. |
Additional Information
Database features
• Extensive search, find and sort capabilities.
• Direct web links to companies web pages
• Comprehensive drug presentation in one record
• Comprehensive presentation of business collaboration in one record
Each company profile
contains:
1. Company Name
2. Address
3. Country
4. Phone
5. Fax
6. Email
7. Web
8. Profile
Each drug is described by:
1. Drug name
2. Company Name
3. Country
4. Synonyms
5. Partner
6. Activity (Active, On-hold,
Terminated etc)
7. Status (Target validation
through Phase III)
8. Compound Data
9. Type of Drug (Drug,
vaccine)
10. Mechanism
11. Target
12. Type of Therapy
13. Descriptives
14. Clinical Information
15. Market Information
16. Side Effects
Each collaboration is described
by:
1. Involved parties
2. Parties countries
3. Date
4. Status (Active, Terminated
etc.)
5. Type of business
collaboration (9 classes)
6. Descriptives
7. Terms
8. BusInt No. (Tracking
number)
Related Markets
Hepatitis Reports
- Chinese Markets for Hepatitis Drugs
- Liver Disease Treatments: The Global Market
- Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market
- Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018
- Hepatitis C Global Clinical Trials Review, H2, 2011